Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene for psychotic symptoms in men with schizophrenia
NCT01481883Phase 4Completed
- Sponsor
- Alfred Health
- Start
- Jan 2012
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raloxifene in schizophrenia, schizoaffective disorder, schizophreniform disorder, sponsored by Alfred Health. Started Jan 2012; status: completed.
02
Drugs
raloxifene
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorder
Beyond the preview
Go deeper on NCT01481883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01481883.